Arrowhead Pharmaceuticals (ARWR) Cash from Discontinued Operations (2010 - 2013)
Arrowhead Pharmaceuticals' (ARWR) quarterly Cash from Discontinued Operations came in at 336.0 in Q1 2013, up 30.29% YoY from 257.89 in Q1 2012, and down 1766.67% on a QoQ basis from 18.0 in Q4 2012.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Cash from Discontinued Operations (2010 - 2013) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 4 years of Cash from Discontinued Operations data on file, last reported at 336.0 in Q1 2013.
- Quarterly Cash from Discontinued Operations rose 30.29% year-over-year to 336.0 in Q1 2013, while the trailing twelve-month figure through Sep 2013 was 354.0 (down 26.43% YoY) and the FY2013 annual result came in at 354.0, down 26.43% from the prior year.
- Cash from Discontinued Operations fell to 336.0 in Q1 2013, from 18.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 2866933.0 in Q1 2011 to a low of 627878.0 in Q3 2010.
- A 4-year average of 148797.45 and a median of 355.0 in 2011 frame the typical range for Cash from Discontinued Operations.
- The widest YoY moves for Cash from Discontinued Operations: up 101.19% in 2012, down 100.02% in 2012.
- Tracing ARWR's Cash from Discontinued Operations over 4 years: stood at 544335.0 in 2010, then jumped by 99.92% to 420.0 in 2011, then jumped by 95.71% to 18.0 in 2012, then sank by 1766.67% to 336.0 in 2013.
- The last three Cash from Discontinued Operations figures came in at 336.0 (Q1 2013), 18.0 (Q4 2012), and 55.0 (Q3 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Arrowhead Pharmaceuticals | 12.40 Bn | 10.80 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | -336.00 |
| Dec 31, 2012 | -18.00 |
| Sep 30, 2012 | -55.00 |
| Jun 30, 2012 | 677.00 |
| Mar 31, 2012 | -482.00 |
| Dec 31, 2011 | -420.00 |
| Sep 30, 2011 | -355.00 |
| Jun 30, 2011 | -56,959.00 |
| Mar 31, 2011 | 2.87 Mn |
| Dec 31, 2010 | -544,335.00 |
| Sep 30, 2010 | -627,878.00 |